The Comparison between Endoscopic Submucosal Dissection and Surgery in Gastric Cancer: A Systematic Review and Meta-Analysis

Table 2

The survival outcome of different studies.

	Ryu [19]	Shin [20]	Chiu [11]	Cho [12]	Fukunaga [22]	Kim [15]	Najmeh [17]	Park [18]
3 YSR (%) (ESD/surgery)	N/A	N/A	94.6%/89.7%	N/A	N/A	EC: N/A; GC: N/A	N/A	80.0%/96.3%
OS (%) (ESD/surgery)	N/A	N/A	N/A	89.8%/90.0%	N/A	EC: 100.5 ± 1.3/84.9 ± 2.6; GC: 93.4 ± 3.2/85.8 ± 5.5 (month)	100%/90.3% (4 years)	N/A
5-year OS (%) (ESD/surgery)	100%/100%	N/A	N/A	N/A	97.1%/85.8%	EC: N/A; GC: N/A	N/A	97.4%/96.1%
DFS (%) (ESD/surgery)	N/A	N/A	N/A	N/A	N/A	EC:93.6 ± 2.5/87.6 ± 2.0; GC: 89.7 ± 3.6/90.4 ± 3.5 (month)	84.6%/82.6%	N/A
5-year DFS (%) (ESD/surgery)	85%/97%	N/A	N/A	N/A	N/A	EC: N/A; GC: N/A	N/A	N/A
5 YSR (%) (ESD/surgery)	N/A	92%/93.3%	N/A	N/A	N/A	EC: N/A; GC: N/A	N/A	N/A
value	5-year DFS: 0.001	0.496	0.44	0.565	0.01	EC:—OS: 0.397, DFS: 0.597; GC: N/A	N/A	3-year SR: <0.001, 5-year OSR: 0.280

ESD: endoscopic submucosal dissection; YSR: year survival rate; SR: survival rate; OS: overall survival; OSR: overall survival rate; DFS: disease-free survival; EC: expanded criteria; GC: guideline criteria. N/A: not available.